Sanara MedTech Inc. Common Stock SMTI

Sanara MedTech Inc. es una empresa de tecnología médica centrada en el desarrollo y comercialización de tecnologías transformadoras para mejorar los resultados clínicos y reducir los gastos de atención médica en los mercados de cirugía y cuidado de heridas crónicas y de la piel. Los productos de la compañía incluyen productos para el cuidado de heridas quirúrgicas, que incluyen CellerateRX Surgical Activated Collagen (Polvo y Gel), y productos para el cuidado de heridas crónicas, que incluyen HYCOL Hydrolyzed Collagen (Polvo y Gel), BIAKOS Skin and Wound Cleanser y BIAKOS Skin and Wound Gel. Los productos para el cuidado de heridas quirúrgicas se utilizan en especialidades que incluyen cirugía cardio-torácica, colorrectal, cirugía general, mano, cabeza y cuello, obstetricia y ginecología de alto riesgo, cirugía de Mohs, neurocirugía, oncología, plástica/reconstructiva, podiátrica, urología y vascular. Los productos para el cuidado de heridas crónicas se utilizan en todo el continuo de atención post-aguda, incluyendo atención domiciliaria, hospicio, consultorios médicos, podólogos, tiendas minoristas, centros de enfermería especializada y centros de cuidado de heridas.

• GlobeNewswire Inc. 8 sept

  MIMEDX to Participate in Upcoming Investor Conferences

  MIMEDX Group reported second quarter 2026 net sales of $64 million and reiterated its full year financial outlook. The company announced plans to acquire Sanara MedTech in a transformational combination aimed at creating a leading regenerative medicine company and expanding MIMEDX's surgical footprint across multiple surgical subspecialties.

  

• GlobeNewswire Inc. 5 ago

  Halper Sadeh LLC is Investigating Whether FBRX, LXFR, SMTI, MKTX are Obtaining Fair Deals for their Shareholders

  Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential violations of federal securities laws and breaches of fiduciary duties related to their proposed acquisitions. The firm is examining whether insiders are receiving substantial benefits unavailable to ordinary shareholders and whether transaction terms limit competing offers. The investigations cover Forte Biosciences' sale to argenx, Luxfer Holdings' sale to Wynnchurch Capital affiliates, Sanara MedTech's sale to MiMedx Group, and MarketAxess Holdings' sale to Intercontinental Exchange.

  

• GlobeNewswire Inc. 4 ago

  Halper Sadeh LLC is Investigating Whether MKTX, SMTI, LNTH are Obtaining Fair Deals for their Shareholders

  Halper Sadeh LLC, an investor rights law firm, is investigating three companies for potential securities law violations and breaches of fiduciary duties related to their proposed acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be limiting superior competing offers.

  

• GlobeNewswire Inc. 30 jul

  BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ), Sanara MedTech Inc. (Nasdaq – SMTI), TriCo Bancshares (Nasdaq – TCBK)

  Law firm Brodsky & Smith announced investigations into four major merger transactions, examining whether the boards of MarketAxess Holdings, CBIZ, Sanara MedTech, and TriCo Bancshares breached fiduciary duties by failing to conduct fair processes and potentially underpaying shareholders. The firm is seeking shareholders to discuss potential class action lawsuits.